Literature DB >> 16802370

Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.

Malin V Jonsson1, Nicolas Delaleu, Karl A Brokstad, Ellen Berggreen, Kathrine Skarstein.   

Abstract

OBJECTIVE: To characterize the chronologic disease course and possible interrelationships between salivary gland inflammation, hyposalivation, and cytokine levels in NOD mice, a model for Sjögren's syndrome (SS).
METHODS: NOD mice of different ages were used to mimic different disease stages of SS. Histopathologic findings and rates of salivary secretion were compared between 8-week-old, 17-week-old, and 24-week-old female mice. In addition, 10 cytokines were analyzed in serum and saliva obtained from NOD and BALB/c mice.
RESULTS: In NOD mice, the salivary flow rate did not change between 8 weeks and 17 weeks of age, while a significant decrease in the salivary flow rate occurred between 17 weeks and 24 weeks of age (P < 0.001). In contrast, significant histopathologic changes in the salivary glands occurred before 17 weeks of age. Chronic inflammatory cell infiltrates were characterized by T and B cell infiltration. Interestingly, in one-third of the mice, proliferating cells were observed in the focal infiltrates. Significant changes in the levels of interleukin-2 (IL-2), IL-5, and granulocyte-macrophage colony-stimulating factor in serum, and in the levels of IL-4 and tumor necrosis factor alpha (TNFalpha) in saliva occurred contemporarily with the decrease in salivary flow. Correlation analyses revealed a negative association between salivary secretion and the levels of IL-4, interferon-gamma, and TNFalpha in saliva obtained from NOD mice, while the correlation with inflammatory changes in the glands was consistently weak.
CONCLUSION: Consistent with previous findings, our results indicate at least 2 phases of SS-like disease in NOD mice. Hyposalivation was preceded by inflammatory changes in the salivary glands, whereas abrupt changes in secretion occurred without significant progression of inflammation. Changes in cytokine levels are an indication of the mechanisms involved in the adaptive immune response in the transition from early to overt disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16802370     DOI: 10.1002/art.21945

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  43 in total

1.  Bone marrow cells are a source of undifferentiated cells to prevent Sjögren's syndrome and to preserve salivary glands function in the non-obese diabetic mice.

Authors:  Saeed Khalili; Younan Liu; Yoshinori Sumita; Ola M Maria; David Blank; Sharon Key; Eva Mezey; Simon D Tran
Journal:  Int J Biochem Cell Biol       Date:  2010-08-21       Impact factor: 5.085

2.  Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice.

Authors:  Patricia K A Mongini; Jill M Kramer; Tomo-O Ishikawa; Harvey Herschman; Donna Esposito
Journal:  Clin Immunol       Date:  2014-03-29       Impact factor: 3.969

Review 3.  Animal models of Sjögren's syndrome.

Authors:  Malin V Jonsson; Nicolas Delaleu; Roland Jonsson
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

4.  Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease.

Authors:  Kevin Gillespie; Isamu Kodani; Douglas P Dickinson; Kalu U E Ogbureke; Amy M Camba; Mengjie Wu; Stephen Looney; Tin-Chun Chu; Haiyan Qin; Frederick Bisch; Mohamed Sharawy; George S Schuster; Stephen D Hsu
Journal:  Life Sci       Date:  2008-09-06       Impact factor: 5.037

Review 5.  Sjögren syndrome: advances in the pathogenesis from animal models.

Authors:  J A Chiorini; D Cihakova; C E Ouellette; P Caturegli
Journal:  J Autoimmun       Date:  2009-10-02       Impact factor: 7.094

6.  Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome.

Authors:  N Roescher; B M Lodde; J L Vosters; P P Tak; M A Catalan; G G Illei; J A Chiorini
Journal:  Oral Dis       Date:  2011-09-14       Impact factor: 3.511

7.  Changes in the Submandibular Salivary Gland Epithelial Cell Subpopulations During Progression of Sjögren's Syndrome-Like Disease in the NOD/ShiLtJ Mouse Model.

Authors:  Elise M Gervais; Kara A Desantis; Nicholas Pagendarm; Deirdre A Nelson; Tone Enger; Kathrine Skarstein; Janicke Liaaen Jensen; Melinda Larsen
Journal:  Anat Rec (Hoboken)       Date:  2015-07-16       Impact factor: 2.064

8.  TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice.

Authors:  J L Vosters; N Roescher; G G Illei; J A Chiorini; P P Tak
Journal:  Oral Dis       Date:  2011-12-29       Impact factor: 3.511

9.  Desiccating environmental stress exacerbates autoimmune lacrimal keratoconjunctivitis in non-obese diabetic mice.

Authors:  Kyung-Chul Yoon; Cintia S De Paiva; Hong Qi; Zhuo Chen; William J Farley; De-Quan Li; Michael E Stern; Stephen C Pflugfelder
Journal:  J Autoimmun       Date:  2007-11-07       Impact factor: 7.094

10.  Vasoactive intestinal peptide inhibits TNF-alpha-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands.

Authors:  Mario Calafat; Luciana Larocca; Valeria Roca; Vanesa Hauk; Nicolás Pregi; Alcira Nesse; Claudia Pérez Leirós
Journal:  Arthritis Res Ther       Date:  2009-04-08       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.